Prolonged intrahepatic cholestasis in acute-onset, severe autoimmune hepatitis

Journal of Gastroenterology

Volumn 32, Issue 3, 1997, Pages 410-413

  Motoo, Yoshiharu ^a   Sawabu, Norio ^a   Watanabe, Hiroyuki ^a   Okai, Takashi ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acute hepatitis; Autoimmune hepatitis; Insulin glucagon therapy; Intrahepatic cholestasis

Indexed keywords

ANTINUCLEAR ANTIBODY; BILIRUBIN; GLUCAGON; INSULIN; PREDNISOLONE; STEROID; URSODEOXYCHOLIC ACID;

AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CASE REPORT; FEMALE; HUMAN; HYPERBILIRUBINEMIA; INTRAHEPATIC CHOLESTASIS; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LABORATORY DIAGNOSIS; LIVER FAILURE; LIVER FUNCTION TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030992302     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934502     Document Type: Article

References (28)

1. Crapper RM, Bhathal PS, Mackay IR, et al. "Acute" autoimmune hepatitis. Digestion 1986;34:216-225
2. Matsushita E, Unoura M, Furusawa A, et al. Study of the mechanisms of development of autoimmune hepatitis (in Japanese with English abstract). Acta Hepat Jpn 1988;29:1357-1361.
3. Kamiyama T, Izumi N, Kojima S, et al. A case of early autoimmune chronic active hepatitis with clinically acute onset and histological features of acute hepatitis. (in Japanese with English abstract). Acta Hepat Jpn 1990;31:565-569.
4. Morimoto H, Wakabayashi T, Suzuki K, et al. Autoimmune hepatitis manifested by clinico-pathological features of acute hepatitis: Report of two cases (in Japanese with English abstract). Acta Hepat Jpn 1991;32:1148-1155.
5. Kuramitsu T, Komatsu M, Ono T, et al. A rare case of autoimmune hepatitis with acute onset (in Japanese with English abstract). Akita J Med 1993;20:467-471.
6. Takamura H, Endo M, Hiranuma M, et al. A case of rapid progress of autoimmune hepatitis in a male of middle age (in Japanese with English abstract). J Nihon Univ Med Assoc 1990;49:983-988.
7. Lefkowitch JH, Apfelbaum TF, Weinberg L, et al. Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis. Liver 1984;4:379-386.
8. Amontree JS, Stuart TD, Bredffeldt JE. Autoimmune chronic active hepatitis masquerading as acute hepatitis. J Clin Gastroenterol 1989;11:303-307.
9. Porta G, Gayotto LCC, Alvarez F. Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr 1990;11:138-140.
10. Sekine K, Saito T, Watanabe H, et al. A patient with fulminant course of lupoid hepatitis improved by plasmapheresis and steroid pulse therapy (in Japanese with English abstract). Gastroenterology (Tokyo) 1990;12:114-119.
11. Nakadate I, Nakamura A, Endo R, et al. Autoimmune hepatitis presenting with acute hepatic failure (in Japanese with English abstract). Acta Hepat Jpn 1993;34:665-671.
12. Ohnishi K, Torimoto Y, Ohhira M, et al. A patient with autoimmune hepatitis recovered from fulminant-like severe hepatic failure (in Japanese). Jpn J Gastroenterol 1994;91:1457-1463.
13. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th ed. Oxford: Blackwell Scientific Publications, 1993:266-268.
14. Okita K, Matsuda S, Hata K, et al. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure. Gastroenterol Jpn 1979;14:453-457.
15. Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatitis group. Hepatology 1993;18:998-1005.
16. Nakanuma Y, Harada K, Nonomura A, et al. Pathology of autoimmune hepatitis and related diseases. In: Nishioka M, Toda G, Zeniya M, (eds) Autoimmune hepatitis. Amsterdam: Elsevier Science, 1994:85-127.
17. Vento S, Garofano T, Di Perri G, et al. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991;337:1183-1187.
18. Rahaman SM, Chira P, Koff RS. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol 1994;89: 106-108.
19. Laskus T, Slusarczyk J. Autoimmune chronic active hepatitis developing after acute type B hepatitis. Dig Dis Sci 1989;34:1294-1297.
20. Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis: An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 1994;18:91-99.
21. Colombato LA, Alvarez F, Cote J, et al. Autoimmune cholangiopathy: The result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 1994;107:1839-1843.
22. Michieletti P, Wanless IR, Katz A, et al. Antimitochondrial antibody-negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis. Gut 1994;35:260-265.
23. Farivar M, Wands JR, Isselbacher KJ, et al. Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med 1976;295:1517-1523.
24. Moris TQ. Choleretic responses to cyclic AMP and theophylline in the dog (abstract). Gastroenterology 1972;62:187.
25. Kaminski DL, Ruwart MJ, Jellinek M. Effect of glucagon on secretin-stimulated bue flow. Am J Physiol 1975;229:1480-1485.
26. Yano T, Noguchi T, Hitaka N, Mizumoto R. Studies on insulin-glucagon therapy for intractable jaundice in surgical patients. Mie Med J 1983;33:217-24.
27. Suzuki K, Katoh A, Sasaki K, et al. A case of Zieve's syndrome which was improved by glucagon-insulin therapy (in Japanese). Kan Tan Sui (J BU Pancreas) 1987;14:979-984.
28. Lebovics E, Schaffner F, Klion FM, et al. Autoimmune chronic active hepatitis in postmentopausal women. Dig Dis Sci 1985;30: 824-828.